202 related articles for article (PubMed ID: 22572474)
1. Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
Vase MØ; Hellberg YK; Larsen CS; Petersen E; Schaumburg H; Bendix K; Ravel C; Bastien P; Christensen M; d'Amore F
Acta Haematol; 2012; 128(1):20-2. PubMed ID: 22572474
[No Abstract] [Full Text] [Related]
2. Visceral leishmaniasis clinically mimicking lymphoma.
Evers G; Pohlen M; Berdel WE; Thoennissen NH; Titze U; Köhler G; Weckesser M; Anthoni C; Mesters RM
Ann Hematol; 2014 May; 93(5):885-7. PubMed ID: 24061787
[No Abstract] [Full Text] [Related]
3. An unwelcome synergy: leishmaniasis and HIV.
Colasanti J; Altamirano J; Espinoza L
Am J Med; 2013 Feb; 126(2):114-6. PubMed ID: 23331437
[No Abstract] [Full Text] [Related]
4. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
[No Abstract] [Full Text] [Related]
5. Visceral leishmaniasis caused by Leishmania infantum in Thailand.
Maharom P; Siripattanapipong S; Mungthin M; Naaglor T; Sukkawee R; Pudkorn R; Wattana W; Wanachiwanawin D; Areechokchai D; Leelayoova S
Southeast Asian J Trop Med Public Health; 2008 Nov; 39(6):988-90. PubMed ID: 19062685
[TBL] [Abstract][Full Text] [Related]
6. Acute renal failure due to visceral leishmaniasis by Leishmania infantum successfully treated with a single high dose of liposomal amphotericin B.
Beltrame A; Arzese A; Camporese A; Rorato G; Crapis M; Tarabini-Castellani G; Boscutti G; Pizzolitto S; Calianno G; Matteelli A; Di Muccio T; Gramiccia M; Viale P
J Travel Med; 2008; 15(5):358-60. PubMed ID: 19006511
[TBL] [Abstract][Full Text] [Related]
7. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
8. Visceral leishmaniasis in a patient with Wegener's granulomatosis.
Sollima S; Corbellino M; Piolini R; Calattini S; Imparato S; Antinori S
Rheumatology (Oxford); 2004 Jul; 43(7):935-7. PubMed ID: 15213342
[No Abstract] [Full Text] [Related]
9. Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge.
Patole S; Burza S; Varghese GM
Int J Infect Dis; 2014 Aug; 25():204-6. PubMed ID: 24927662
[TBL] [Abstract][Full Text] [Related]
10. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
[TBL] [Abstract][Full Text] [Related]
11. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
12. Miltefosine for Indian visceral leishmaniasis.
Roca B
N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12608397
[No Abstract] [Full Text] [Related]
13. Skin rash for 15 years.
Montelius S; Maasho K; Pratlong F; Lebbad M; Gregory L; Akuffo H
Lancet; 1998 Oct; 352(9138):1438. PubMed ID: 9807991
[No Abstract] [Full Text] [Related]
14. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
Faucher JF; Morquin D; Reynes J; Chirouze C; Hoen B; Le Moing V
Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
[TBL] [Abstract][Full Text] [Related]
15. Miltefosine for Indian visceral leishmaniasis.
Agarwal PK
N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12606744
[No Abstract] [Full Text] [Related]
16. Visceral leishmaniasis in children: a review.
Palumbo E
Minerva Pediatr; 2010 Aug; 62(4):389-95. PubMed ID: 20940672
[TBL] [Abstract][Full Text] [Related]
17. Post-kala-azar dermal leishmaniasis due to Leishmania infantum in an HIV-negative patient treated with miltefosine.
Monge-Maillo B; Norman FF; Chamorro-Tojeiro S; Gioia F; Pérez-Molina JA; Chicharro C; Moreno J; López-Vélez R
J Travel Med; 2022 Nov; 29(7):. PubMed ID: 34668558
[No Abstract] [Full Text] [Related]
18. Visceral leishmaniasis simulating chronic liver disease: successful treatment with miltefosine.
Avasthi R; Chaudhary SC; Khanna S
Indian J Med Microbiol; 2009; 27(1):85-6. PubMed ID: 19172077
[No Abstract] [Full Text] [Related]
19. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
[TBL] [Abstract][Full Text] [Related]
20. Current diagnosis and treatment of visceral leishmaniasis.
Mondal S; Bhattacharya P; Ali N
Expert Rev Anti Infect Ther; 2010 Aug; 8(8):919-44. PubMed ID: 20695748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
